Three Healthcare Shifts Have Moved The Market Since January. Your H2 Plan Probably Hasn't Caught Up.
Ah, summer. Pipeline's quiet and calendars are open... the perfect conditions to take stock, course-correct and walk into the fall with a stronger plan.
The slow weeks are the best planning window youâll get all year. Use them to rebuild the foundation now, so Q4 converts and next summerâs pipeline stays strong.
I hope summerâs treating you well. If itâs anything like mine, youâre a little off your routine, kids in and out of camps, a vacation here, a pool afternoon there. The calendar looks different every week. Some days itâs a pleasant blur, which makes it hard to believe weâre already a week out from July and halfway through the year.
Healthcare buyers are off doing all those things too, so deals go quiet and pipeline thins during these lazy summer days. A marketing engine with solid direction keeps producing while people are at the lake or home with kids on summer break. The content still goes out, nurtures still run, and the pipeline keeps filling, slower than usual but filling.
A pile of disconnected tactics does the opposite: it stops the moment the person running it logs off. When one marketer holds the whole thing together by hand, the engine idles the week they take PTO.
So a steep drop tells you something real. Your marketing team doesnât have an engine. They have effort, and effort doesnât run on its own.
Even a solid plan is already stale
A weak foundation is one problem the summer exposes. Even if your pipeline holds through the summer, the plan you wrote in January is likely out of date.
GTM Partners published research this year on why most go-to-market plans break by Q2. The cause had nothing to do with execution. The annual plan leaders approved in Q4 stopped matching the business they were running by spring. Headcount shifts, pipeline mix changes. The macro picture moved. All of these things that couldnât have been accounted for.
Thatâs truer in health tech than almost anywhere. Since January, the Series B bar has climbed, new state healthcare-AI laws take effect July 1 in Indiana, Arizona and Tennessee, and buyers stopped asking for AI pilots and started asking for proof. A plan built before those shifts is a plan for a market that no longer exists.
So whether the summer exposes a weak foundation or just an outdated plan, the move is the same. Use these slow weeks to replan around whatâs true now, on a tighter cadence than once a year.
Three shifts that should anchor your plan
Three things should shape how you plan the back half of the year. They point the same direction, which makes the planning simpler than it looks. Every one of them focuses on proof and depth over volume and noise.
Funding tightened, and the sales cycle got longer
Digital health funding is up, but itâs concentrated at the top. Rock Health reported $4 billion across 110 deals in Q1 2026, with 59% of it going to just 12 mega-deals. For everyone outside that handful, capital is harder to raise and the bar is higher. A Series B now expects revenue and a path to profitability, not just growth alone.
That discipline shows up on the buying side, too. Health systems are budgeting under pressure, and their purchases reflect it. Enterprise deals now move through committees of 12 to 15 people across clinical, IT, finance, and compliance, over cycles that run 6 to 12 months or longer.
What it means for your marketing: the fast pilot closed by a single champion is mostly gone. Youâre nurturing a group decision over a long horizon, so plan for it.
Buyers moved from pilots to proof, and theyâre consolidating
The AI experimentation phase is ending. Eliciting Insights found 75% of health systems are now using or planning to use AI, and the percent running three or more tools jumped to 59%. Adoption isnât the question anymore. What buyers want to know is whether it pays back, and roughly 60% of CIOs report orders to pause new spend unless it shows return inside 12 months.
At the same time, theyâre consolidating. Theyâre cutting vendor counts and favoring platforms over point solutions. FinThrive found nearly 60% of revenue-cycle leaders plan to consolidate vendors within three years, and 71% plan to lean less on third parties.
Two things follow for how you position.
Iâve said this for a while, âAI poweredâ is table stakes now, so leading with it does nothing. Rework your positioning around proof instead.
Every tool now has to survive one question inside the committee: why not just fold this into a platform we already own? Your reps need an answer ready. Arm them with assets that hold up when a deal reaches the people who were never in the demo.
AI answer engines are collapsing zero-click search
The way buyers find you is changing fast. AI answer engines are absorbing the traffic that used to land on your site. SparkToro found roughly 59% of US searches already ended without a click in 2024, and its 2026 follow-up found fewer than one in three Google searches now sends a click anywhere. Buyers ask ChatGPT, Claude and Gemini during evaluation.
What it means: content that isnât built to be cited by an AI disappears from the shortlist right as buyers form it. Ranking on page one matters less when thereâs no click to win.
Your H2 checklist
These three shifts all ask for the same thing: stop selling activity and start proving outcomes, to a slower committee thatâs vetting you through an AI before you ever get the meeting. Thatâs a foundation rebuild, not another campaign, and itâs exactly the kind of work the quiet weeks are made for.
The work splits into two horizons. Some of it you start now, while things are still slow. The rest you set up this fall, before next yearâs budgets harden.
Do now (July to September)
Audit what survives the summer. What keeps running without a hand on it is your foundation. What stops is your exposure.
Rework positioning around proof. Case studies with real numbers, documented outcomes, third-party validation.
Build a sales-enablement kit. Value-analysis briefs, an ROI calculator, security and compliance one-pagers, and EHR-integration proof, so your reps can answer the consolidation question.
Stand up the basics of AI search. Structured, citable content with named clinical authors who carry credibility in a field that demands it.
Set up next (October to December)
Align demand gen to the longer committee cycle before 2027 budgets lock.
Create content tracks and nurtures for each buyer (clinical, financial, IT, compliance) that stay warm for months, not the six weeks a typical drip covers.
Build account-based motion around your named target accounts.
Shift website measurement away from raw traffic and toward whether AI engines cite you to AI citations, and whether branded search is climbing
If youâre raising, pressure-test the story against the higher Series B bar while you still have time to close the gaps.
The bottom line
The summer slowdown either exposes a gap or proves your foundation. The companies that treat the quiet weeks as planning time convert in Q4.
This isnât a knock on your marketer. Theyâre missing these shifts because theyâre in it, heads-down keeping everything running through the summer. Nobody on the inside has the distance to see the whole system at once.
An outside read gives you what the inside canât: objectivity (because thereâs no plan to defend), pattern recognition (because the same shifts are playing out across a dozen companies at your stage) and a cadence that turns a slow month into a replan instead of a coast.
If youâre not sure which part of your H2 plan is weakest, a Marketing Gap Analysis gives you a clear read on whatâs working and what isnât. If you already know and want the plan built, letâs talk about a 90-Day Roadmap that turns these quiet weeks into the foundation Q4 runs on.
Either way, the calendarâs on your side now. It wonât be in October.
If youâve put real money into marketing and still canât tell whatâs working, letâs find which layer youâre missing.
Keep Reading
Why Health Tech Companies Stop Trusting Marketing â the case for treating marketing as one connected system instead of a pile of disconnected tactics. Start here if youâre new.
The Revenue Hiding in Your Pipeline â what conversion youâre already leaving on the table before you spend another dollar on leads.
You Probably Donât Have The Marketing Problem You Think You Have â the four patterns these four fixes map back to, and why founders usually misread which one theyâre in.
Everyone Buys Marketing Execution. Almost No One Buys Direction. â agency, full-time hire, senior doer or fractional leader. Which one fits, and which one most leaders default to.
About the Author
Heather Lodge, Fractional Chief Marketing Officer, The Hybrid CMO
Heather helps bring clarity to growing health tech and healthcare service companies that have the marketing talent but lack the strategic direction. She helps establish clear market positioning, lead focused account-based marketing programs and build the systems and teams needed to scale effectively. Heather takes the team and the budget you already have and makes them work harder. The right problems, the systems underneath, every dollar tied back to pipeline.